Anti-Aging, Neuroprotection, and Cognitive Enhancement
The intersection of peptide science with longevity research and cognitive neuroscience has produced some of the most promising compounds for healthy aging. From telomere-extending peptides like epitalon to mitochondrial-targeted therapies like SS-31 and nootropic peptides like semax and selank, this hub covers the frontier of anti-aging and brain health research.
Research Areas
- Telomere biology: epitalon and telomerase activation
- Senolytic therapy: Foxo4-DRI for selective senescent cell clearance
- Mitochondrial peptides: SS-31, humanin, NAD+ precursors
- Nootropic peptides: semax, selank, dihexa, cerebrolysin, adamax
- Bioregulators: pinealon, vilon, glandokort for organ-specific rejuvenation
The Peptide Approach to Longevity
Aging is driven by interconnected processes: telomere shortening, mitochondrial dysfunction, cellular senescence, oxidative stress accumulation, and declining hormone signaling. Peptide therapies target these processes at the molecular level, offering precision interventions that small molecules often cannot achieve.
On the cognitive side, nootropic peptides cross the blood-brain barrier to support neurogenesis, synaptic plasticity, and neuroprotection. Semax and selank are among the most well-studied, with decades of clinical use in certain countries. Newer compounds like dihexa show extraordinary potency for neurotrophic signaling. Our articles examine the evidence, mechanisms, and practical considerations for each compound.
